Search Results - "Romero, Iris L."
-
1
Metformin Targets Central Carbon Metabolism and Reveals Mitochondrial Requirements in Human Cancers
Published in Cell metabolism (08-11-2016)“…Repurposing metformin for cancer therapy is attractive due to its safety profile, epidemiological evidence, and encouraging data from human clinical trials…”
Get full text
Journal Article -
2
Adipocyte-Induced FABP4 Expression in Ovarian Cancer Cells Promotes Metastasis and Mediates Carboplatin Resistance
Published in Cancer research (Chicago, Ill.) (15-04-2020)“…Adipocytes are critical for ovarian cancer cells to home to the omentum, but the metabolic changes initiated by this interaction are unknown. To this end, we…”
Get full text
Journal Article -
3
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
Published in Nature medicine (01-11-2011)“…Ovarian tumors preferentially metastasize to the omentum, a peritoneal fat layer. This report proposes that the reasons for this predilection stem from the…”
Get full text
Journal Article -
4
Old drug, new trick: Repurposing metformin for gynecologic cancers?
Published in Gynecologic oncology (01-12-2014)“…Abstract Objective There is increasing pre-clinical and clinical evidence that metformin, a commonly used diabetes medication, has a protective effect in…”
Get full text
Journal Article -
5
Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion
Published in The Journal of clinical investigation (01-10-2014)“…Ovarian cancer (OvCa) metastasizes to organs in the abdominal cavity, such as the omentum, which are covered by a single layer of mesothelial cells…”
Get full text
Journal Article -
6
Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models
Published in American journal of obstetrics and gynecology (01-04-2015)“…Objective There is increasing preclinical evidence indicating that metformin, a medication commonly used for type 2 diabetes mellitus, may protect against…”
Get full text
Journal Article -
7
Molecular pathways: trafficking of metabolic resources in the tumor microenvironment
Published in Clinical cancer research (15-02-2015)“…A model of tumor metabolism is proposed that describes how the complementary metabolic functions of the local stroma and the tumor cells contribute to cancer…”
Get full text
Journal Article -
8
SPHK1 Is a Novel Target of Metformin in Ovarian Cancer
Published in Molecular cancer research (01-04-2019)“…The role of phospholipid signaling in ovarian cancer is poorly understood. Sphingosine-1-phosphate (S1P) is a bioactive metabolite of sphingosine that has been…”
Get full text
Journal Article -
9
Relationship of Type II Diabetes and Metformin Use to Ovarian Cancer Progression, Survival, and Chemosensitivity
Published in Obstetrics and gynecology (New York. 1953) (01-01-2012)“…OBJECTIVE:To estimate whether metformin use by ovarian cancer patients with type II diabetes was associated with improved survival. METHODS:We reviewed the…”
Get full text
Journal Article -
10
Mesothelial Cell HIF1α Expression Is Metabolically Downregulated by Metformin to Prevent Oncogenic Tumor-Stromal Crosstalk
Published in Cell reports (Cambridge) (17-12-2019)“…The tumor microenvironment (TME) plays a pivotal role in cancer progression, and, in ovarian cancer (OvCa), the primary TME is the omentum. Here, we show that…”
Get full text
Journal Article -
11
Association of Metformin Use with Outcomes in Advanced Endometrial Cancer Treated with Chemotherapy
Published in PloS one (20-01-2016)“…There is increasing evidence that metformin, a commonly used treatment for diabetes, might have the potential to be repurposed as an economical and safe cancer…”
Get full text
Journal Article -
12
Foretinib (GSK1363089), an Orally Available Multikinase Inhibitor of c-Met and VEGFR-2, Blocks Proliferation, Induces Anoikis, and Impairs Ovarian Cancer Metastasis
Published in Clinical cancer research (15-06-2011)“…Currently, there are no approved targeted therapies for the treatment of ovarian cancer, despite the fact that it is the most lethal gynecological malignancy…”
Get full text
Journal Article -
13
Statin therapy is associated with improved survival in patients with non-serous-papillary epithelial ovarian cancer: a retrospective cohort analysis
Published in PloS one (13-08-2014)“…To determine whether statin use is associated with improved epithelial ovarian cancer (OvCa) survival. This is a single-institution retrospective cohort review…”
Get full text
Journal Article -
14
Loss of BRCA1 in the Cells of Origin of Ovarian Cancer Induces Glycolysis: A Window of Opportunity for Ovarian Cancer Chemoprevention
Published in Cancer prevention research (Philadelphia, Pa.) (01-04-2017)“…Mutations in the breast cancer susceptibility gene 1 ( ) are associated with an increased risk of developing epithelial ovarian cancer. However, beyond the…”
Get full text
Journal Article -
15
Adipose tissue and adipocytes support tumorigenesis and metastasis
Published in Biochimica et biophysica acta (01-10-2013)“…Adipose tissue influences tumor development in two major ways. First, obese individuals have a higher risk of developing certain cancers (endometrial,…”
Get full text
Journal Article -
16
Changes in numbers and academic ranks of Hispanic faculty in departments of obstetrics and gynecology
Published in American journal of obstetrics and gynecology (01-12-2023)Get full text
Journal Article -
17
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
Published in Nature reviews. Cancer (01-11-2015)“…This Opinion article outlines a set of research priorities, based on discussions held at the 2015 Helene Harris Memorial Trust Ovarian Cancer Action meeting,…”
Get full text
Journal Article -
18
CD95 promotes tumour growth
Published in Nature (London) (27-05-2010)“…CD95 (also called Fas and APO-1) is a prototypical death receptor that regulates tissue homeostasis mainly in the immune system through the induction of…”
Get full text
Journal Article -
19
Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers
Published in Clinical cancer research (15-03-2019)“…To establish a cohort of high-risk women undergoing intensive surveillance for breast cancer. We performed dynamic contrast-enhanced MRI every 6 months in…”
Get full text
Journal Article -
20
Obstetrics and Gynecology Resident Physician Experiences with Lesbian, Gay, Bisexual, Transgender and Queer Healthcare Training
Published in Medical science educator (01-04-2021)“…Purpose To assess obstetrician-gynecologist (Ob/Gyn) resident experiences with and preferences for lesbian, gay, bisexual, transgender, and queer (LGBTQ)…”
Get full text
Journal Article